<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-02-01" modified="2017-05-10" version="194">
<accession>Q02763</accession>
<accession>A8K6W0</accession>
<accession>B4DH20</accession>
<accession>B4DHD3</accession>
<accession>D3DRK5</accession>
<accession>E7EWI2</accession>
<accession>Q5TCU2</accession>
<accession>Q8IV34</accession>
<name>TIE2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Angiopoietin-1 receptor</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Endothelial tyrosine kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Tunica interna endothelial cell kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine kinase with Ig and EGF homology domains-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase receptor TEK</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase receptor TIE-2</fullName>
<shortName>hTIE2</shortName>
</alternativeName>
<alternativeName>
<fullName>p140 TEK</fullName>
</alternativeName>
<cdAntigenName>CD202b</cdAntigenName>
</protein>
<gene>
<name type="primary">TEK</name>
<name type="synonym">TIE2</name>
<name type="synonym">VMCM</name>
<name type="synonym">VMCM1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Oncogene" volume="8" first="663" last="670">
<title>Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta.</title>
<authorList>
<person name="Ziegler S.F."/>
<person name="Bird T.A."/>
<person name="Schneringer J.A."/>
<person name="Schooley K.A."/>
<person name="Baum P.R."/>
</authorList>
<dbReference type="PubMed" id="8382358"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT PRO-346</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<scope>VARIANT PRO-346</scope>
<source>
<tissue>Brain</tissue>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT PRO-346</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT PRO-346</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 23-37</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="Science" volume="277" first="55" last="60">
<title>Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.</title>
<authorList>
<person name="Maisonpierre P.C."/>
<person name="Suri C."/>
<person name="Jones P.F."/>
<person name="Bartunkova S."/>
<person name="Wiegand S.J."/>
<person name="Radziejewski C."/>
<person name="Compton D.L."/>
<person name="McClain J."/>
<person name="Aldrich T.H."/>
<person name="Papadopoulos N."/>
<person name="Daly T.J."/>
<person name="Davis S."/>
<person name="Sato T.N."/>
<person name="Yancopoulos G.D."/>
</authorList>
<dbReference type="PubMed" id="9204896"/>
<dbReference type="DOI" id="10.1126/science.277.5322.55"/>
</citation>
<scope>FUNCTION AS RECEPTOR FOR ANGPT1 AND ANGPT2</scope>
<scope>INTERACTION WITH ANGPT1 AND ANGPT2</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Angiogenesis" volume="4" first="123" last="131">
<title>Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood.</title>
<authorList>
<person name="Reusch P."/>
<person name="Barleon B."/>
<person name="Weindel K."/>
<person name="Martiny-Baron G."/>
<person name="Godde A."/>
<person name="Siemeister G."/>
<person name="Marme D."/>
</authorList>
<dbReference type="PubMed" id="11806244"/>
<dbReference type="DOI" id="10.1023/A:1012226627813"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Biochemistry" volume="40" first="10243" last="10253">
<title>Mechanistic effects of autophosphorylation on receptor tyrosine kinase catalysis: enzymatic characterization of Tie2 and phospho-Tie2.</title>
<authorList>
<person name="Murray B.W."/>
<person name="Padrique E.S."/>
<person name="Pinko C."/>
<person name="McTigue M.A."/>
</authorList>
<dbReference type="PubMed" id="11513602"/>
<dbReference type="DOI" id="10.1021/bi010959e"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ENZYME REGULATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION AT TYR-860; TYR-992 AND TYR-1108</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Blood" volume="102" first="2482" last="2490">
<title>Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1.</title>
<authorList>
<person name="Cascone I."/>
<person name="Audero E."/>
<person name="Giraudo E."/>
<person name="Napione L."/>
<person name="Maniero F."/>
<person name="Philips M.R."/>
<person name="Collard J.G."/>
<person name="Serini G."/>
<person name="Bussolino F."/>
</authorList>
<dbReference type="PubMed" id="12816861"/>
<dbReference type="DOI" id="10.1182/blood-2003-03-0670"/>
</citation>
<scope>FUNCTION IN REGULATION OF PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; ENDOTHELIAL CELL MIGRATION AND REORGANIZATION OF THE ACTIN CYTOSKELETON</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Circ. Res." volume="92" first="630" last="636">
<title>The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2.</title>
<authorList>
<person name="Hughes D.P."/>
<person name="Marron M.B."/>
<person name="Brindle N.P."/>
</authorList>
<dbReference type="PubMed" id="12609966"/>
<dbReference type="DOI" id="10.1161/01.RES.0000063422.38690.DC"/>
</citation>
<scope>INTERACTION WITH TNIP2</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF LYS-855</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="FASEB J." volume="18" first="1200" last="1208">
<title>Biological characterization of angiopoietin-3 and angiopoietin-4.</title>
<authorList>
<person name="Lee H.J."/>
<person name="Cho C.H."/>
<person name="Hwang S.J."/>
<person name="Choi H.H."/>
<person name="Kim K.T."/>
<person name="Ahn S.Y."/>
<person name="Kim J.H."/>
<person name="Oh J.L."/>
<person name="Lee G.M."/>
<person name="Koh G.Y."/>
</authorList>
<dbReference type="PubMed" id="15284220"/>
<dbReference type="DOI" id="10.1096/fj.03-1466com"/>
</citation>
<scope>FUNCTION IN REGULATION OF ANGIOGENESIS; CELL SURVIVAL; CELL MIGRATION AND ACTIVATION OF AKT1</scope>
<scope>DOMAIN</scope>
<scope>INTERACTION WITH ANGPT1; ANGPT2 AND ANGPT4</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="13224" last="13233">
<title>Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells.</title>
<authorList>
<person name="Audero E."/>
<person name="Cascone I."/>
<person name="Maniero F."/>
<person name="Napione L."/>
<person name="Arese M."/>
<person name="Lanfrancone L."/>
<person name="Bussolino F."/>
</authorList>
<dbReference type="PubMed" id="14665640"/>
<dbReference type="DOI" id="10.1074/jbc.M307456200"/>
</citation>
<scope>FUNCTION AS ANGPT1 RECEPTOR IN PHOSPHORYLATION OF SHC1 AND PIK3R1; REGULATION OF CELL MIGRATION AND ANGIOGENESIS</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF TYR-1102</scope>
<scope>PHOSPHORYLATION AT TYR-1102</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH SHC1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="169" first="239" last="243">
<title>Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2.</title>
<authorList>
<person name="Saharinen P."/>
<person name="Kerkela K."/>
<person name="Ekman N."/>
<person name="Marron M."/>
<person name="Brindle N."/>
<person name="Lee G.M."/>
<person name="Augustin H."/>
<person name="Koh G.Y."/>
<person name="Alitalo K."/>
</authorList>
<dbReference type="PubMed" id="15851516"/>
<dbReference type="DOI" id="10.1083/jcb.200411105"/>
</citation>
<scope>INTERACTION WITH TIE1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION AS RECEPTOR FOR ANGPT1 IN PHOSPHORYLATION OF TIE1</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF LYS-855</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Nat. Cell Biol." volume="10" first="513" last="526">
<title>Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1.</title>
<authorList>
<person name="Fukuhara S."/>
<person name="Sako K."/>
<person name="Minami T."/>
<person name="Noda K."/>
<person name="Kim H.Z."/>
<person name="Kodama T."/>
<person name="Shibuya M."/>
<person name="Takakura N."/>
<person name="Koh G.Y."/>
<person name="Mochizuki N."/>
</authorList>
<dbReference type="PubMed" id="18425120"/>
<dbReference type="DOI" id="10.1038/ncb1714"/>
</citation>
<scope>FUNCTION AS ANGPT1 RECEPTOR IN ACTIVATION OF AKT1 OR MAPK1/ERK2 AND MAPK3/ERK1; REGULATION OF ENDOTHELIAL CELL MIGRATION AND CELL SPREADING</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Nat. Cell Biol." volume="10" first="527" last="537">
<title>Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts.</title>
<authorList>
<person name="Saharinen P."/>
<person name="Eklund L."/>
<person name="Miettinen J."/>
<person name="Wirkkala R."/>
<person name="Anisimov A."/>
<person name="Winderlich M."/>
<person name="Nottebaum A."/>
<person name="Vestweber D."/>
<person name="Deutsch U."/>
<person name="Koh G.Y."/>
<person name="Olsen B.R."/>
<person name="Alitalo K."/>
</authorList>
<dbReference type="PubMed" id="18425119"/>
<dbReference type="DOI" id="10.1038/ncb1715"/>
</citation>
<scope>FUNCTION AS ANGPT1 RECEPTOR IN ACTIVATION OF AKT1 OR MAPK1/ERK2 AND MAPK3/ERK1; REGULATION OF ENDOTHELIAL CELL MIGRATION AND REGULATION OF FOCAL ADHESION ASSEMBLY</scope>
<scope>INTERACTION WITH TIE1</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Angiogenesis" volume="12" first="25" last="33">
<title>Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells.</title>
<authorList>
<person name="Yacyshyn O.K."/>
<person name="Lai P.F.H."/>
<person name="Forse K."/>
<person name="Teichert-Kuliszewska K."/>
<person name="Jurasz P."/>
<person name="Stewart D.J."/>
</authorList>
<dbReference type="PubMed" id="19116766"/>
<dbReference type="DOI" id="10.1007/s10456-008-9126-0"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPRB</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Biochem. J." volume="423" first="375" last="380">
<title>Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation.</title>
<authorList>
<person name="Wehrle C."/>
<person name="Van Slyke P."/>
<person name="Dumont D.J."/>
</authorList>
<dbReference type="PubMed" id="19689429"/>
<dbReference type="DOI" id="10.1042/BJ20091010"/>
</citation>
<scope>INTERACTION WITH CBL</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Cell Biol." volume="185" first="657" last="671">
<title>VE-PTP controls blood vessel development by balancing Tie-2 activity.</title>
<authorList>
<person name="Winderlich M."/>
<person name="Keller L."/>
<person name="Cagna G."/>
<person name="Broermann A."/>
<person name="Kamenyeva O."/>
<person name="Kiefer F."/>
<person name="Deutsch U."/>
<person name="Nottebaum A.F."/>
<person name="Vestweber D."/>
</authorList>
<dbReference type="PubMed" id="19451274"/>
<dbReference type="DOI" id="10.1083/jcb.200811159"/>
</citation>
<scope>INTERACTION WITH PTPRB</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-596</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="2011" last="2022">
<title>Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.</title>
<authorList>
<person name="Yuan H.T."/>
<person name="Khankin E.V."/>
<person name="Karumanchi S.A."/>
<person name="Parikh S.M."/>
</authorList>
<dbReference type="PubMed" id="19223473"/>
<dbReference type="DOI" id="10.1128/MCB.01472-08"/>
</citation>
<scope>FUNCTION AS RECEPTOR FOR ANGPT1 AND ANGPT2 IN ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE AND AKT1; STIMULATION OF ENDOTHELIAL CELL SURVIVAL AND MIGRATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Histol. Histopathol." volume="23" first="773" last="780">
<title>Tie2: a journey from normal angiogenesis to cancer and beyond.</title>
<authorList>
<person name="Martin V."/>
<person name="Liu D."/>
<person name="Fueyo J."/>
<person name="Gomez-Manzano C."/>
</authorList>
<dbReference type="PubMed" id="18366015"/>
<dbReference type="DOI" id="10.14670/HH-23.773"/>
</citation>
<scope>REVIEW ON FUNCTION; INTERACTION WITH EFFECTOR AND SCAFFOLDING PROTEINS</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Exp. Mol. Med." volume="41" first="133" last="139">
<title>Tie2 is tied at the cell-cell contacts and to extracellular matrix by angiopoietin-1.</title>
<authorList>
<person name="Fukuhara S."/>
<person name="Sako K."/>
<person name="Noda K."/>
<person name="Nagao K."/>
<person name="Miura K."/>
<person name="Mochizuki N."/>
</authorList>
<dbReference type="PubMed" id="19293632"/>
<dbReference type="DOI" id="10.3858/emm.2009.41.3.016"/>
</citation>
<scope>REVIEW ON SUBCELLULAR LOCATION AND CONTEXT-SPECIFIC SIGNALING</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Nat. Rev. Mol. Cell Biol." volume="10" first="165" last="177">
<title>Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.</title>
<authorList>
<person name="Augustin H.G."/>
<person name="Koh G.Y."/>
<person name="Thurston G."/>
<person name="Alitalo K."/>
</authorList>
<dbReference type="PubMed" id="19234476"/>
<dbReference type="DOI" id="10.1038/nrm2639"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Histol. Histopathol." volume="25" first="387" last="396">
<title>Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis.</title>
<authorList>
<person name="Fukuhara S."/>
<person name="Sako K."/>
<person name="Noda K."/>
<person name="Zhang J."/>
<person name="Minami M."/>
<person name="Mochizuki N."/>
</authorList>
<dbReference type="PubMed" id="20054809"/>
<dbReference type="DOI" id="10.14670/HH-25.387"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Nat. Rev. Cancer" volume="10" first="575" last="585">
<title>Targeting the ANGPT-TIE2 pathway in malignancy.</title>
<authorList>
<person name="Huang H."/>
<person name="Bhat A."/>
<person name="Woodnutt G."/>
<person name="Lappe R."/>
</authorList>
<dbReference type="PubMed" id="20651738"/>
<dbReference type="DOI" id="10.1038/nrc2894"/>
</citation>
<scope>REVIEW ON SIGNALING</scope>
<scope>ENZYME REGULATION</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2000" name="Structure" volume="8" first="1105" last="1113">
<title>Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail.</title>
<authorList>
<person name="Shewchuk L.M."/>
<person name="Hassell A.M."/>
<person name="Ellis B."/>
<person name="Holmes W.D."/>
<person name="Davis R."/>
<person name="Horne E.L."/>
<person name="Kadwell S.H."/>
<person name="McKee D.D."/>
<person name="Moore J.T."/>
</authorList>
<dbReference type="PubMed" id="11080633"/>
<dbReference type="DOI" id="10.1016/S0969-2126(00)00516-5"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 808-1124</scope>
<scope>ACTIVE SITE</scope>
<scope>ENZYME REGULATION</scope>
<scope>PREDICTION OF ATP-BINDING REGION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Nat. Struct. Mol. Biol." volume="13" first="524" last="532">
<title>Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex.</title>
<authorList>
<person name="Barton W.A."/>
<person name="Tzvetkova-Robev D."/>
<person name="Miranda E.P."/>
<person name="Kolev M.V."/>
<person name="Rajashankar K.R."/>
<person name="Himanen J.P."/>
<person name="Nikolov D.B."/>
</authorList>
<dbReference type="PubMed" id="16732286"/>
<dbReference type="DOI" id="10.1038/nsmb1101"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 23-445 ALONE AND IN COMPLEX WITH ANGPT2</scope>
<scope>GLYCOSYLATION AT ASN-140</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Bioorg. Med. Chem. Lett." volume="17" first="2886" last="2889">
<title>Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors.</title>
<authorList>
<person name="Hodous B.L."/>
<person name="Geuns-Meyer S.D."/>
<person name="Hughes P.E."/>
<person name="Albrecht B.K."/>
<person name="Bellon S."/>
<person name="Caenepeel S."/>
<person name="Cee V.J."/>
<person name="Chaffee S.C."/>
<person name="Emery M."/>
<person name="Fretland J."/>
<person name="Gallant P."/>
<person name="Gu Y."/>
<person name="Johnson R.E."/>
<person name="Kim J.L."/>
<person name="Long A.M."/>
<person name="Morrison M."/>
<person name="Olivieri P.R."/>
<person name="Patel V.F."/>
<person name="Polverino A."/>
<person name="Rose P."/>
<person name="Wang L."/>
<person name="Zhao H."/>
</authorList>
<dbReference type="PubMed" id="17350837"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2007.02.067"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 808-1124 IN COMPLEX WITH TRIAZINE DERIVATIVE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="J. Med. Chem." volume="50" first="611" last="626">
<title>Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor.</title>
<authorList>
<person name="Hodous B.L."/>
<person name="Geuns-Meyer S.D."/>
<person name="Hughes P.E."/>
<person name="Albrecht B.K."/>
<person name="Bellon S."/>
<person name="Bready J."/>
<person name="Caenepeel S."/>
<person name="Cee V.J."/>
<person name="Chaffee S.C."/>
<person name="Coxon A."/>
<person name="Emery M."/>
<person name="Fretland J."/>
<person name="Gallant P."/>
<person name="Gu Y."/>
<person name="Hoffman D."/>
<person name="Johnson R.E."/>
<person name="Kendall R."/>
<person name="Kim J.L."/>
<person name="Long A.M."/>
<person name="Morrison M."/>
<person name="Olivieri P.R."/>
<person name="Patel V.F."/>
<person name="Polverino A."/>
<person name="Rose P."/>
<person name="Tempest P."/>
<person name="Wang L."/>
<person name="Whittington D.A."/>
<person name="Zhao H."/>
</authorList>
<dbReference type="PubMed" id="17253678"/>
<dbReference type="DOI" id="10.1021/jm061107l"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 808-1124 IN COMPLEX WITH TRIAZINE DERIVATIVE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Bioorg. Med. Chem. Lett." volume="19" first="6670" last="6674">
<title>Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo.</title>
<authorList>
<person name="Luke R.W."/>
<person name="Ballard P."/>
<person name="Buttar D."/>
<person name="Campbell L."/>
<person name="Curwen J."/>
<person name="Emery S.C."/>
<person name="Griffen A.M."/>
<person name="Hassall L."/>
<person name="Hayter B.R."/>
<person name="Jones C.D."/>
<person name="McCoull W."/>
<person name="Mellor M."/>
<person name="Swain M.L."/>
<person name="Tucker J.A."/>
</authorList>
<dbReference type="PubMed" id="19854647"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2009.10.001"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) OF 802-1124 IN COMPLEX WITH THIAZOLOPYRIMIDINE DERIVATIVE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="32">
<citation type="submission" date="2010-01" db="PDB data bank">
<title>Crystal structure of cytoplasmic kinase domain of Tie2 complexed with inhibitor CEP11207.</title>
<authorList>
<person name="Fedorov A.A."/>
<person name="Fedorov E.V."/>
<person name="Pauletti D."/>
<person name="Meyer S.L."/>
<person name="Hudkins R.L."/>
<person name="Almo S.C."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 808-1124 IN COMPLEX WITH CEP11207</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1996" name="Cell" volume="87" first="1181" last="1190">
<title>Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.</title>
<authorList>
<person name="Vikkula M."/>
<person name="Boon L.M."/>
<person name="Carraway K.L. III"/>
<person name="Calvert J.T."/>
<person name="Diamonti A.J."/>
<person name="Goumnerov B."/>
<person name="Pasyk K.A."/>
<person name="Marchuk D.A."/>
<person name="Warman M.L."/>
<person name="Cantley L.C."/>
<person name="Mulliken J.B."/>
<person name="Olse B.R."/>
</authorList>
<dbReference type="PubMed" id="8980225"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)81814-0"/>
</citation>
<scope>VARIANT VMCM TRP-849</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1999" name="Hum. Mol. Genet." volume="8" first="1279" last="1289">
<title>Allelic and locus heterogeneity in inherited venous malformations.</title>
<authorList>
<person name="Calvert J.T."/>
<person name="Riney T.J."/>
<person name="Kontos C.D."/>
<person name="Cha E.H."/>
<person name="Prieto V.G."/>
<person name="Shea C.R."/>
<person name="Berg J.N."/>
<person name="Nevin N.C."/>
<person name="Simpson S.A."/>
<person name="Pasyk K.A."/>
<person name="Speer M.C."/>
<person name="Peters K.G."/>
<person name="Marchuk D.A."/>
</authorList>
<dbReference type="PubMed" id="10369874"/>
<dbReference type="DOI" id="10.1093/hmg/8.7.1279"/>
</citation>
<scope>VARIANTS VMCM TRP-849 AND SER-897</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] ASN-117</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ASN-117; THR-148; VAL-226; ILE-486; LEU-600; PHE-634; ILE-676; THR-724; ALA-883 AND VAL-1124</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Nat. Genet." volume="41" first="118" last="124">
<title>Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.</title>
<authorList>
<person name="Limaye N."/>
<person name="Wouters V."/>
<person name="Uebelhoer M."/>
<person name="Tuominen M."/>
<person name="Wirkkala R."/>
<person name="Mulliken J.B."/>
<person name="Eklund L."/>
<person name="Boon L.M."/>
<person name="Vikkula M."/>
</authorList>
<dbReference type="PubMed" id="19079259"/>
<dbReference type="DOI" id="10.1038/ng.272"/>
</citation>
<scope>INVOLVEMENT IN VMCM</scope>
<scope>INVOLVEMENT IN DISEASE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS VMCM TRP-849</scope>
<scope>VARIANTS HIS-897; PHE-897; SER-897; PHE-914; CYS-915; LEU-915 AND ILE-917</scope>
<scope>CHARACTERIZATION OF VARIANTS HIS-897; PHE-897; SER-897; PHE-914; CYS-915; LEU-915 AND ILE-917</scope>
<scope>PHOSPHORYLATION AT TYR-1102</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="Eur. J. Hum. Genet." volume="18" first="414" last="420">
<title>Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects.</title>
<authorList>
<person name="Wouters V."/>
<person name="Limaye N."/>
<person name="Uebelhoer M."/>
<person name="Irrthum A."/>
<person name="Boon L.M."/>
<person name="Mulliken J.B."/>
<person name="Enjolras O."/>
<person name="Baselga E."/>
<person name="Berg J."/>
<person name="Dompmartin A."/>
<person name="Ivarsson S.A."/>
<person name="Kangesu L."/>
<person name="Lacassie Y."/>
<person name="Murphy J."/>
<person name="Teebi A.S."/>
<person name="Penington A."/>
<person name="Rieu P."/>
<person name="Vikkula M."/>
</authorList>
<dbReference type="PubMed" id="19888299"/>
<dbReference type="DOI" id="10.1038/ejhg.2009.193"/>
</citation>
<scope>VARIANTS VMCM TRP-849; CYS-897; HIS-915; CYS-918; LEU-919; SER-925 AND ASN-1100</scope>
<scope>CHARACTERIZATION OF VARIANTS VMCM TRP-849; SER-897; HIS-915; CYS-918; LEU-919; SER-925 AND ASN-1100</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2016" name="J. Clin. Invest." volume="126" first="2575" last="2587">
<title>Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.</title>
<authorList>
<person name="Souma T."/>
<person name="Tompson S.W."/>
<person name="Thomson B.R."/>
<person name="Siggs O.M."/>
<person name="Kizhatil K."/>
<person name="Yamaguchi S."/>
<person name="Feng L."/>
<person name="Limviphuvadh V."/>
<person name="Whisenhunt K.N."/>
<person name="Maurer-Stroh S."/>
<person name="Yanovitch T.L."/>
<person name="Kalaydjieva L."/>
<person name="Azmanov D.N."/>
<person name="Finzi S."/>
<person name="Mauri L."/>
<person name="Javadiyan S."/>
<person name="Souzeau E."/>
<person name="Zhou T."/>
<person name="Hewitt A.W."/>
<person name="Kloss B."/>
<person name="Burdon K.P."/>
<person name="Mackey D.A."/>
<person name="Allen K.F."/>
<person name="Ruddle J.B."/>
<person name="Lim S.H."/>
<person name="Rozen S."/>
<person name="Tran-Viet K.N."/>
<person name="Liu X."/>
<person name="John S."/>
<person name="Wiggs J.L."/>
<person name="Pasutto F."/>
<person name="Craig J.E."/>
<person name="Jin J."/>
<person name="Quaggin S.E."/>
<person name="Young T.L."/>
</authorList>
<dbReference type="PubMed" id="27270174"/>
<dbReference type="DOI" id="10.1172/JCI85830"/>
</citation>
<scope>INVOLVEMENT IN GLC3E</scope>
<scope>VARIANTS GLC3E 19-THR--ARG-210 DEL; TYR-233; ASN-294 AND CYS-611</scope>
<scope>CHARACTERIZATION OF VARIANTS GLC3E 19-THR--ARG-210 DEL; TYR-233; ASN-294 AND CYS-611</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF CYS-224</scope>
</reference>
<comment type="function">
<text evidence="15 16 18 21 27 28 29 32 37 41">Tyrosine-protein kinase that acts as cell-surface receptor for ANGPT1, ANGPT2 and ANGPT4 and regulates angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Has anti-inflammatory effects by preventing the leakage of proinflammatory plasma proteins and leukocytes from blood vessels. Required for normal angiogenesis and heart development during embryogenesis. Required for post-natal hematopoiesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts. In quiescent vessels, ANGPT1 oligomers recruit TEK to cell-cell contacts, forming complexes with TEK molecules from adjoining cells, and this leads to preferential activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascades. In migrating endothelial cells that lack cell-cell adhesions, ANGT1 recruits TEK to contacts with the extracellular matrix, leading to the formation of focal adhesion complexes, activation of PTK2/FAK and of the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, and ultimately to the stimulation of sprouting angiogenesis. ANGPT1 signaling triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Signaling is modulated by ANGPT2 that has lower affinity for TEK, can promote TEK autophosphorylation in the absence of ANGPT1, but inhibits ANGPT1-mediated signaling by competing for the same binding site. Signaling is also modulated by formation of heterodimers with TIE1, and by proteolytic processing that gives rise to a soluble TEK extracellular domain. The soluble extracellular domain modulates signaling by functioning as decoy receptor for angiopoietins. TEK phosphorylates DOK2, GRB7, GRB14, PIK3R1; SHC1 and TIE1.</text>
</comment>
<comment type="catalytic activity">
<text evidence="9 12 14 16 21 32 39">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="11 12 24 26 35 37">Angiopoietin binding leads to receptor dimerization and activation by autophosphorylation at Tyr-992 on the kinase activation loop. Inhibited by staurosporine, K252a, PP2, damnacanthal, SB203580, CEP-11207, CEP-11981 and CE-245677. Inhibited by triazine, thienopyrimidine and thiazolopyrimidine derivatives.</text>
</comment>
<comment type="subunit">
<text evidence="14 16 18 21 22 24 26 28 33 34 35 41 42">Homodimer. Heterodimer with TIE1. Interacts with ANGPT1, ANGPT2 and ANGPT4. At cell-cell contacts in quiescent cells, forms a signaling complex composed of ANGPT1 plus TEK molecules from two adjoining cells. In the absence of endothelial cell-cell contacts, interaction with ANGPT1 mediates contacts with the extracellular matrix. Interacts with PTPRB; this promotes endothelial cell-cell adhesion. Interacts with DOK2, GRB2, GRB7, GRB14, PIK3R1 and PTPN11/SHP2. Colocalizes with DOK2 at contacts with the extracellular matrix in migrating cells. Interacts (tyrosine phosphorylated) with TNIP2. Interacts (tyrosine phosphorylated) with SHC1 (via SH2 domain).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2257090"/>
<interactant intactId="EBI-2912111">
<id>O15123</id>
<label>ANGPT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2257090"/>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2257090"/>
<interactant intactId="EBI-1265766">
<id>P23467</id>
<label>PTPRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2257090"/>
<interactant intactId="EBI-1341">
<id>P08575</id>
<label>PTPRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2257090"/>
<interactant intactId="EBI-2264500">
<id>Q12913</id>
<label>PTPRJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2257090"/>
<interactant intactId="EBI-474052">
<id>Q15262</id>
<label>PTPRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2257090"/>
<interactant intactId="EBI-723739">
<id>Q16827</id>
<label>PTPRO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="28 29 30 38">Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="28 29 38">Cell junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="47">Cell junction</location>
<location evidence="47">Focal adhesion</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Secreted</location>
</subcellularLocation>
<text evidence="13 28 29">Recruited to cell-cell contacts in quiescent endothelial cells (PubMed:18425120, PubMed:18425119). Colocalizes with the actin cytoskeleton and at actin stress fibers during cell spreading. Recruited to the lower surface of migrating cells, especially the rear end of the cell. Proteolytic processing gives rise to a soluble extracellular domain that is secreted (PubMed:11806244).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q02763-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q02763-2</id>
<name>2</name>
<sequence type="described" ref="VSP_042138"/>
</isoform>
<isoform>
<id>Q02763-3</id>
<name>3</name>
<sequence type="described" ref="VSP_042137 VSP_042138 VSP_042139"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13 39">Detected in umbilical vein endothelial cells. Proteolytic processing gives rise to a soluble extracellular domain that is detected in blood plasma (at protein level). Predominantly expressed in endothelial cells and their progenitors, the angioblasts. Has been directly found in placenta and lung, with a lower level in umbilical vein endothelial cells, brain and kidney.</text>
</comment>
<comment type="domain">
<text evidence="18">The soluble extracellular domain is functionally active in angiopoietin binding and can modulate the activity of the membrane-bound form by competing for angiopoietins.</text>
</comment>
<comment type="PTM">
<text evidence="13">Proteolytic processing leads to the shedding of the extracellular domain (soluble TIE-2 alias sTIE-2).</text>
</comment>
<comment type="PTM">
<text evidence="12 16">Autophosphorylated on tyrosine residues in response to ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Autophosphorylation occurs in a sequential manner, where Tyr-992 in the kinase activation loop is phosphorylated first, followed by autophosphorylation at Tyr-1108 and at additional tyrosine residues. ANGPT1-induced phosphorylation is impaired during hypoxia, due to increased expression of ANGPT2. Phosphorylation is important for interaction with GRB14, PIK3R1 and PTPN11. Phosphorylation at Tyr-1102 is important for interaction with SHC1, GRB2 and GRB7. Phosphorylation at Tyr-1108 is important for interaction with DOK2 and for coupling to downstream signal transduction pathways in endothelial cells. Dephosphorylated by PTPRB.</text>
</comment>
<comment type="PTM">
<text evidence="34">Ubiquitinated. The phosphorylated receptor is ubiquitinated and internalized, leading to its degradation.</text>
</comment>
<comment type="disease" evidence="10 30 36 40">
<disease id="DI-01500">
<name>Dominantly inherited venous malformations</name>
<acronym>VMCM</acronym>
<description>An error of vascular morphogenesis characterized by dilated, serpiginous channels.</description>
<dbReference type="MIM" id="600195"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="30">Somatic mutations of TEK are associated with solitary and multiple sporadic venous malformations.</text>
</comment>
<comment type="disease">
<text>May play a role in a range of diseases with a vascular component, including neovascularization of tumors, psoriasis and inflammation.</text>
</comment>
<comment type="disease" evidence="38">
<disease id="DI-04901">
<name>Glaucoma 3, primary congenital, E</name>
<acronym>GLC3E</acronym>
<description>An autosomal dominant form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor.</description>
<dbReference type="MIM" id="617272"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the protein kinase superfamily. Tyr protein kinase family. Tie subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/TEKID42517ch9p21.html"/>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="L06139">
<property type="protein sequence ID" value="AAA61139.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291775">
<property type="protein sequence ID" value="BAF84464.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK294887">
<property type="protein sequence ID" value="BAG57981.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295043">
<property type="protein sequence ID" value="BAG58094.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133411">
<property type="protein sequence ID" value="CAI16055.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL355432">
<property type="protein sequence ID" value="CAI16055.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL355433">
<property type="protein sequence ID" value="CAI16055.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58571.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58572.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC035514">
<property type="protein sequence ID" value="AAH35514.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6519.1">
<molecule id="Q02763-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS75825.1">
<molecule id="Q02763-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS78389.1">
<molecule id="Q02763-3"/>
</dbReference>
<dbReference type="PIR" id="I58388">
<property type="entry name" value="I58388"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000450.2">
<property type="nucleotide sequence ID" value="NM_000459.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001277006.1">
<property type="nucleotide sequence ID" value="NM_001290077.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001277007.1">
<property type="nucleotide sequence ID" value="NM_001290078.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.89640"/>
<dbReference type="PDB" id="1FVR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=808-1124"/>
</dbReference>
<dbReference type="PDB" id="2GY5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=23-445"/>
</dbReference>
<dbReference type="PDB" id="2GY7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="B=23-445"/>
</dbReference>
<dbReference type="PDB" id="2OO8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="X=808-1124"/>
</dbReference>
<dbReference type="PDB" id="2OSC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=808-1124"/>
</dbReference>
<dbReference type="PDB" id="2P4I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=808-1124"/>
</dbReference>
<dbReference type="PDB" id="2WQB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=802-1124"/>
</dbReference>
<dbReference type="PDB" id="3BEA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A=917-935"/>
</dbReference>
<dbReference type="PDB" id="3L8P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=808-1124"/>
</dbReference>
<dbReference type="PDB" id="4K0V">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.51"/>
<property type="chains" value="A=23-542"/>
</dbReference>
<dbReference type="PDB" id="4X3J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=802-1122"/>
</dbReference>
<dbReference type="PDBsum" id="1FVR"/>
<dbReference type="PDBsum" id="2GY5"/>
<dbReference type="PDBsum" id="2GY7"/>
<dbReference type="PDBsum" id="2OO8"/>
<dbReference type="PDBsum" id="2OSC"/>
<dbReference type="PDBsum" id="2P4I"/>
<dbReference type="PDBsum" id="2WQB"/>
<dbReference type="PDBsum" id="3BEA"/>
<dbReference type="PDBsum" id="3L8P"/>
<dbReference type="PDBsum" id="4K0V"/>
<dbReference type="PDBsum" id="4X3J"/>
<dbReference type="ProteinModelPortal" id="Q02763"/>
<dbReference type="SMR" id="Q02763"/>
<dbReference type="BioGrid" id="112869">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="DIP" id="DIP-6047N"/>
<dbReference type="IntAct" id="Q02763">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000369375"/>
<dbReference type="BindingDB" id="Q02763"/>
<dbReference type="ChEMBL" id="CHEMBL4128"/>
<dbReference type="DrugBank" id="DB00415">
<property type="generic name" value="Ampicillin"/>
</dbReference>
<dbReference type="DrugBank" id="DB08221">
<property type="generic name" value="N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05294">
<property type="generic name" value="Vandetanib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05153">
<property type="generic name" value="XL184"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1842"/>
<dbReference type="iPTMnet" id="Q02763"/>
<dbReference type="PhosphoSitePlus" id="Q02763"/>
<dbReference type="UniCarbKB" id="Q02763"/>
<dbReference type="BioMuta" id="TEK"/>
<dbReference type="DMDM" id="218511853"/>
<dbReference type="PaxDb" id="Q02763"/>
<dbReference type="PeptideAtlas" id="Q02763"/>
<dbReference type="PRIDE" id="Q02763"/>
<dbReference type="DNASU" id="7010"/>
<dbReference type="Ensembl" id="ENST00000380036">
<molecule id="Q02763-1"/>
<property type="protein sequence ID" value="ENSP00000369375"/>
<property type="gene ID" value="ENSG00000120156"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000406359">
<molecule id="Q02763-2"/>
<property type="protein sequence ID" value="ENSP00000383977"/>
<property type="gene ID" value="ENSG00000120156"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000519097">
<molecule id="Q02763-3"/>
<property type="protein sequence ID" value="ENSP00000430686"/>
<property type="gene ID" value="ENSG00000120156"/>
</dbReference>
<dbReference type="GeneID" id="7010"/>
<dbReference type="KEGG" id="hsa:7010"/>
<dbReference type="UCSC" id="uc003zqi.5">
<molecule id="Q02763-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7010"/>
<dbReference type="DisGeNET" id="7010"/>
<dbReference type="GeneCards" id="TEK"/>
<dbReference type="GeneReviews" id="TEK"/>
<dbReference type="HGNC" id="HGNC:11724">
<property type="gene designation" value="TEK"/>
</dbReference>
<dbReference type="HPA" id="CAB010359"/>
<dbReference type="HPA" id="HPA073265"/>
<dbReference type="MalaCards" id="TEK"/>
<dbReference type="MIM" id="600195">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600221">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617272">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q02763"/>
<dbReference type="OpenTargets" id="ENSG00000120156"/>
<dbReference type="Orphanet" id="2451">
<property type="disease" value="Mucocutaneous venous malformations"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36441"/>
<dbReference type="eggNOG" id="KOG0200">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00810000125384"/>
<dbReference type="HOGENOM" id="HOG000049232"/>
<dbReference type="HOVERGEN" id="HBG007316"/>
<dbReference type="InParanoid" id="Q02763"/>
<dbReference type="KO" id="K05121"/>
<dbReference type="OMA" id="CHEDTGE"/>
<dbReference type="OrthoDB" id="EOG091G00RL"/>
<dbReference type="PhylomeDB" id="Q02763"/>
<dbReference type="TreeFam" id="TF317568"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210993">
<property type="pathway name" value="Tie2 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="SignaLink" id="Q02763"/>
<dbReference type="SIGNOR" id="Q02763"/>
<dbReference type="ChiTaRS" id="TEK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q02763"/>
<dbReference type="GeneWiki" id="TEK_tyrosine_kinase"/>
<dbReference type="GenomeRNAi" id="7010"/>
<dbReference type="PRO" id="PR:Q02763"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000120156"/>
<dbReference type="CleanEx" id="HS_TEK"/>
<dbReference type="ExpressionAtlas" id="Q02763">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q02763">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009925">
<property type="term" value="C:basal plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005815">
<property type="term" value="C:microtubule organizing center"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005902">
<property type="term" value="C:microvillus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019838">
<property type="term" value="F:growth factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004872">
<property type="term" value="F:receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060216">
<property type="term" value="P:definitive hemopoiesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001958">
<property type="term" value="P:endochondral ossification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001935">
<property type="term" value="P:endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072012">
<property type="term" value="P:glomerulus vasculature development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060347">
<property type="term" value="P:heart trabecula formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000352">
<property type="term" value="P:negative regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000251">
<property type="term" value="P:positive regulation of actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010595">
<property type="term" value="P:positive regulation of endothelial cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001938">
<property type="term" value="P:positive regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051894">
<property type="term" value="P:positive regulation of focal adhesion assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902533">
<property type="term" value="P:positive regulation of intracellular signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051259">
<property type="term" value="P:protein oligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000351">
<property type="term" value="P:regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032878">
<property type="term" value="P:regulation of establishment or maintenance of cell polarity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043114">
<property type="term" value="P:regulation of vascular permeability"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051591">
<property type="term" value="P:response to cAMP"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002040">
<property type="term" value="P:sprouting angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034446">
<property type="term" value="P:substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048014">
<property type="term" value="P:Tie signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00063">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="6"/>
</dbReference>
<dbReference type="InterPro" id="IPR013032">
<property type="entry name" value="EGF-like_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000742">
<property type="entry name" value="EGF-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR018941">
<property type="entry name" value="Tyr_kin_Tie2_Ig-like_dom-1_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00041">
<property type="entry name" value="fn3"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Pfam" id="PF10430">
<property type="entry name" value="Ig_Tie2_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00181">
<property type="entry name" value="EGF"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00060">
<property type="entry name" value="FN3"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00022">
<property type="entry name" value="EGF_1"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS01186">
<property type="entry name" value="EGF_2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50026">
<property type="entry name" value="EGF_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50853">
<property type="entry name" value="FN3"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0245">EGF-like domain</keyword>
<keyword id="KW-0955">Glaucoma</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="19">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="chain" description="Angiopoietin-1 receptor" id="PRO_0000024474">
<location>
<begin position="23"/>
<end position="1124"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="5">
<location>
<begin position="23"/>
<end position="748"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="749"/>
<end position="769"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="770"/>
<end position="1124"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="44"/>
<end position="123"/>
</location>
</feature>
<feature type="domain" description="EGF-like 1" evidence="6">
<location>
<begin position="210"/>
<end position="252"/>
</location>
</feature>
<feature type="domain" description="EGF-like 2" evidence="6">
<location>
<begin position="254"/>
<end position="299"/>
</location>
</feature>
<feature type="domain" description="EGF-like 3" evidence="6">
<location>
<begin position="301"/>
<end position="341"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="350"/>
<end position="440"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 1" evidence="8">
<location>
<begin position="447"/>
<end position="541"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 2" evidence="8">
<location>
<begin position="545"/>
<end position="636"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 3" evidence="8">
<location>
<begin position="641"/>
<end position="735"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="7">
<location>
<begin position="824"/>
<end position="1096"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="45">
<location>
<begin position="830"/>
<end position="838"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="46">
<location>
<position position="964"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="45">
<location>
<position position="855"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="12">
<location>
<position position="860"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="12">
<location>
<position position="992"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="16 38">
<location>
<position position="1102"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="12">
<location>
<position position="1108"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="22">
<location>
<position position="140"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="158"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="399"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="438"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="464"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="560"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="31">
<location>
<position position="596"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="649"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="691"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="44"/>
<end position="102"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="211"/>
<end position="220"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="224"/>
<end position="233"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="227"/>
<end position="240"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="242"/>
<end position="251"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="255"/>
<end position="264"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="268"/>
<end position="274"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="280"/>
<end position="287"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="289"/>
<end position="298"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="302"/>
<end position="311"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="315"/>
<end position="323"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="317"/>
<end position="329"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="331"/>
<end position="340"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="370"/>
<end position="424"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042137" evidence="44">
<location>
<begin position="18"/>
<end position="121"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_042138" evidence="44">
<location>
<begin position="300"/>
<end position="342"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042139" evidence="44">
<location>
<position position="788"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC3E; formation of protein aggregates." id="VAR_078045" evidence="38">
<location>
<begin position="19"/>
<end position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In breast cancer samples; infiltrating ductal carcinoma; somatic mutation." id="VAR_035714" evidence="23 25">
<original>K</original>
<variation>N</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35969327." id="VAR_041855" evidence="25">
<original>I</original>
<variation>T</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35814893." id="VAR_041856" evidence="25">
<original>A</original>
<variation>V</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC3E; enhanced proteasomal degradation." id="VAR_078046" evidence="38">
<original>C</original>
<variation>Y</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC3E; unknown pathological significance; 10-fold decrease of Tyr-1102 phosphorylation; no effect on membrane location." id="VAR_078047" evidence="38">
<original>K</original>
<variation>N</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs682632." id="VAR_048002" evidence="17 20 39 43">
<original>Q</original>
<variation>P</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34032300." id="VAR_048003">
<original>T</original>
<variation>I</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1334811." id="VAR_024578" evidence="25">
<original>V</original>
<variation>I</variation>
<location>
<position position="486"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35030851." id="VAR_041857" evidence="25">
<original>V</original>
<variation>L</variation>
<location>
<position position="600"/>
</location>
</feature>
<feature type="sequence variant" description="In GLC3E; reduced response to ligand; loss of ligand-induced phosphorylation; no effect on basal membrane location." id="VAR_078048" evidence="38">
<original>Y</original>
<variation>C</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35378598." id="VAR_041858" evidence="25">
<original>L</original>
<variation>F</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56367117." id="VAR_041859" evidence="25">
<original>V</original>
<variation>I</variation>
<location>
<position position="676"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4631561." id="VAR_041860" evidence="25">
<original>A</original>
<variation>T</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="sequence variant" description="In VMCM; increased ligand-independent autophosphorylation and kinase activation; no effect on location at membrane; dbSNP:rs80338908." id="VAR_006352" evidence="10 30 36 40">
<original>R</original>
<variation>W</variation>
<location>
<position position="849"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian serous carcinoma sample; somatic mutation." id="VAR_041861" evidence="25">
<original>P</original>
<variation>A</variation>
<location>
<position position="883"/>
</location>
</feature>
<feature type="sequence variant" description="In VMCM; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909." id="VAR_066606" evidence="36">
<original>Y</original>
<variation>C</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with multiple sporadic venous malformations; increased ligand-independent autophosphorylation; the hyperphosphorylation increases when associated with Leu-915." id="VAR_078049" evidence="30">
<original>Y</original>
<variation>F</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation." id="VAR_078050" evidence="30">
<original>Y</original>
<variation>H</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="sequence variant" description="In VMCM; also found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909." id="VAR_008716" evidence="10 30 36">
<original>Y</original>
<variation>S</variation>
<location>
<position position="897"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with solitary and multiple sporadic venous malformations; increased ligand-independent autophosphorylation; novel location at endoplasmic reticulum and Golgi apparatus; partially retained at endoplasmic reticulum and Golgi apparatus." id="VAR_078051" evidence="30">
<original>L</original>
<variation>F</variation>
<location>
<position position="914"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation." id="VAR_078052" evidence="30">
<original>R</original>
<variation>C</variation>
<location>
<position position="915"/>
</location>
</feature>
<feature type="sequence variant" description="In VMCM; strongly increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs387906745." id="VAR_066607" evidence="36">
<original>R</original>
<variation>H</variation>
<location>
<position position="915"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with multiple sporadic venous malformations; increased ligand-independent autophosphorylation; the autophosphorylation increases when associated with Phe-897." id="VAR_078053" evidence="30">
<original>R</original>
<variation>L</variation>
<location>
<position position="915"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation." id="VAR_078054" evidence="30">
<original>S</original>
<variation>I</variation>
<location>
<position position="917"/>
</location>
</feature>
<feature type="sequence variant" description="In VMCM; strongly increased ligand-independent autophosphorylation and kinase activation." id="VAR_066608" evidence="36">
<original>R</original>
<variation>C</variation>
<location>
<position position="918"/>
</location>
</feature>
<feature type="sequence variant" description="In VMCM; increased ligand-independent autophosphorylation and kinase activation." id="VAR_066609" evidence="36">
<original>V</original>
<variation>L</variation>
<location>
<position position="919"/>
</location>
</feature>
<feature type="sequence variant" description="In VMCM; increased ligand-independent autophosphorylation and kinase activation." id="VAR_066610" evidence="36">
<original>A</original>
<variation>S</variation>
<location>
<position position="925"/>
</location>
</feature>
<feature type="sequence variant" description="In VMCM; strongly increased ligand-independent autophosphorylation and kinase activation." id="VAR_066611" evidence="36">
<original>K</original>
<variation>N</variation>
<location>
<position position="1100"/>
</location>
</feature>
<feature type="sequence variant" description="In a renal clear cell carcinoma sample; somatic mutation." id="VAR_041862" evidence="25">
<original>A</original>
<variation>V</variation>
<location>
<position position="1124"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces protein abundance." evidence="38">
<original>C</original>
<variation>S</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="14 21">
<original>K</original>
<variation>R</variation>
<location>
<position position="855"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with SHC1." evidence="16">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1102"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG58094." ref="2" evidence="45">
<original>F</original>
<variation>L</variation>
<location>
<position position="536"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA61139." ref="1" evidence="45">
<original>T</original>
<variation>I</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH35514." ref="5" evidence="45">
<original>QQ</original>
<variation>HH</variation>
<location>
<begin position="939"/>
<end position="940"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="26"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="56"/>
<end position="59"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="74"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="80"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="98"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="109"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="127"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="139"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="153"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="160"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="167"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="172"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="187"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="198"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="202"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="215"/>
<end position="217"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="235"/>
<end position="237"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="246"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="259"/>
<end position="261"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="271"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="279"/>
<end position="281"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="282"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="286"/>
<end position="288"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="328"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="361"/>
<end position="366"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="369"/>
<end position="373"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="380"/>
<end position="382"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="383"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="396"/>
<end position="400"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="405"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="411"/>
<end position="414"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="416"/>
<end position="418"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="420"/>
<end position="428"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="431"/>
<end position="439"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="816"/>
<end position="818"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="821"/>
<end position="823"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="825"/>
<end position="831"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="833"/>
<end position="835"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="837"/>
<end position="845"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="848"/>
<end position="858"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="864"/>
<end position="866"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="868"/>
<end position="876"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="888"/>
<end position="894"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="897"/>
<end position="902"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="910"/>
<end position="915"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="919"/>
<end position="922"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="924"/>
<end position="929"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="932"/>
<end position="936"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="938"/>
<end position="957"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="967"/>
<end position="969"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="970"/>
<end position="972"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="974"/>
<end position="976"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="978"/>
<end position="980"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="986"/>
<end position="989"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1002"/>
<end position="1004"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1007"/>
<end position="1012"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1017"/>
<end position="1032"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1038"/>
<end position="1041"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1044"/>
<end position="1050"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1051"/>
<end position="1053"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1065"/>
<end position="1074"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1079"/>
<end position="1081"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1085"/>
<end position="1097"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1098"/>
<end position="1100"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1118"/>
<end position="1120"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1FVR"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GY5"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OO8"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2P4I"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00076"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00316"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10369874"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11080633"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11513602"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11806244"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12609966"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12816861"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14665640"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15284220"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15851516"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16732286"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17253678"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17350837"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18366015"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18425119"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18425120"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19079259"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19223473"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19451274"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19689429"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19854647"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19888299"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20651738"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27270174"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8382358"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8980225"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9204896"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source ref="32"/>
</evidence>
<evidence key="43" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000305"/>
<evidence key="46" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11080633"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19293632"/>
</source>
</evidence>
<sequence length="1124" mass="125830" checksum="E739DEC3E4FEB124" modified="2008-12-16" version="2" precursor="true">
MDSLASLVLCGVSLLLSGTVEGAMDLILINSLPLVSDAETSLTCIASGWRPHEPITIGRD
FEALMNQHQDPLEVTQDVTREWAKKVVWKREKASKINGAYFCEGRVRGEAIRIRTMKMRQ
QASFLPATLTMTVDKGDNVNISFKKVLIKEEDAVIYKNGSFIHSVPRHEVPDILEVHLPH
AQPQDAGVYSARYIGGNLFTSAFTRLIVRRCEAQKWGPECNHLCTACMNNGVCHEDTGEC
ICPPGFMGRTCEKACELHTFGRTCKERCSGQEGCKSYVFCLPDPYGCSCATGWKGLQCNE
ACHPGFYGPDCKLRCSCNNGEMCDRFQGCLCSPGWQGLQCEREGIQRMTPKIVDLPDHIE
VNSGKFNPICKASGWPLPTNEEMTLVKPDGTVLHPKDFNHTDHFSVAIFTIHRILPPDSG
VWVCSVNTVAGMVEKPFNISVKVLPKPLNAPNVIDTGHNFAVINISSEPYFGDGPIKSKK
LLYKPVNHYEAWQHIQVTNEIVTLNYLEPRTEYELCVQLVRRGEGGEGHPGPVRRFTTAS
IGLPPPRGLNLLPKSQTTLNLTWQPIFPSSEDDFYVEVERRSVQKSDQQNIKVPGNLTSV
LLNNLHPREQYVVRARVNTKAQGEWSEDLTAWTLSDILPPQPENIKISNITHSSAVISWT
ILDGYSISSITIRYKVQGKNEDQHVDVKIKNATITQYQLKGLEPETAYQVDIFAENNIGS
SNPAFSHELVTLPESQAPADLGGGKMLLIAILGSAGMTCLTVLLAFLIILQLKRANVQRR
MAQAFQNVREEPAVQFNSGTLALNRKVKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLK
ARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL
AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF
IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD
VWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPY
ERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>